Orange Book product · Generic (ANDA)
LITHIUM CITRATE
LITHIUM CITRATE
Generic (ANDA)ANDA 218036TE AARX RUBICON RESEARCH
At a glance
Aug 14, 2023
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 14, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
LITHIUM CITRATE
Strength
EQ 300MG CARBONATE/5ML
Dosage form
SYRUP
Route
ORAL
TE code
AA
Application
ANDA 218036
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of LITHIUM CITRATE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
